AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

EFFETCS OF MİNDFULNESS-BASED STRESS REDUCTION İN WOMEN WİTH CORONARY ARTERY DİSEASE

RecruitingNAAges 18 Years - 50 YearsFemaleTC Erciyes University
💬

In plain words

What the trial is, and whether it could suit you

Coronary artery disease (CAD) is a common cardiovascular condition characterized by the narrowing or blockage of the coronary arteries that supply oxygen-rich blood to the heart muscle. CAD represents a significant cause of morbidity and mortality, particularly among individuals aged 40 and older, affecting millions of men and women worldwide. Patients with CAD experience not only physical symptoms but also psychological challenges, including stress and anxiety, which can negatively impact quality of life. In recent years, mindfulness-based interventions have emerged as scientifically supported approaches to help individuals with chronic diseases manage stress and enhance emotional regulation skills. While the existing literature includes studies evaluating the effects of mindfulness-based interventions in CAD and other cardiovascular conditions, most investigations address mixed patient

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * Diagnosed with coronary artery disease (CAD) for at least 1 month. * Score of 14 or higher on the Short Form of the State-Trait Anxiety Inventory (STAI-SF) at baseline. * At least primary school education. * Age between 18 and 50 years. * Sexually active. * Having an active social network. Exclusion Criteria: * Individuals with hearing or language impairments that would hinder communication. * Women who have entered menopause. * Women with psychiatric disorders. Discontinuation Criteria: * Participants who choose to withdraw from the study. * Participants who miss two intervention sessions. * Participants with incomplete data on study forms.
💊

What it tests

  • Mindfulness-Based Intervention Program
📍

Where

1 site
Kayseri Şehir Hastanesi
Kayseri, Turkey (Türkiye)
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy